Validation of an Artificial Intelligence-Based Ultrasound Imaging System for Quantifying Muscle Architecture Parameters of the Rectus Femoris in Disease-Related Malnutrition (DRM).

Journal: Nutrients
PMID:

Abstract

(1) Background: The aim was to validate an AI-based system compared to the classic method of reading ultrasound images of the rectus femur (RF) muscle in a real cohort of patients with disease-related malnutrition. (2) Methods: One hundred adult patients with DRM aged 18 to 85 years were enrolled. The risk of DRM was assessed by the Global Leadership Initiative on Malnutrition (GLIM). The variation, reproducibility, and reliability of measurements for the RF subcutaneous fat thickness (SFT), muscle thickness (MT), and cross-sectional area (CSA), were measured conventionally with the incorporated tools of a portable ultrasound imaging device (method A) and compared with the automated quantification of the ultrasound imaging system (method B). (3) Results: Measurements obtained using method A (i.e., conventionally) and method B (i.e., raw images analyzed by AI), showed similar values with no significant differences in absolute values and coefficients of variation, 58.39-57.68% for SFT, 30.50-28.36% for MT, and 36.50-36.91% for CSA, respectively. The Intraclass Correlation Coefficient (ICC) for reliability and consistency analysis between methods A and B showed correlations of 0.912 and 95% CI [0.872-0.940] for SFT, 0.960 and 95% CI [0.941-0.973] for MT, and 0.995 and 95% CI [0.993-0.997] for CSA; the Bland-Altman Analysis shows that the spread of points is quite uniform around the bias lines with no evidence of strong bias for any variable. (4) Conclusions: The study demonstrated the consistency and reliability of this new automatic system based on machine learning and AI for the quantification of ultrasound imaging of the muscle architecture parameters of the rectus femoris muscle compared with the conventional method of measurement.

Authors

  • Sergio García-Herreros
    DAWAKO Medtech S.L., Parc Cientìfic de la Universitat de Valencia, Calle del Catedratic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain.
  • Juan Jose López Gómez
    Investigation Centre Endocrinology and Nutrition, Faculty of Medicine, University of Valladolid, 47003 Valladolid, Spain.
  • Angela Cebria
    DAWAKO Medtech S.L., Parc Cientìfic de la Universitat de Valencia, Calle del Catedratic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain.
  • Olatz Izaola
    Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School, Department of Endocrinology and Nutrition Hospital Clinico Universitario, University of Valladolid, Valladolid Spain.
  • Pablo Salvador Coloma
    DAWAKO Medtech S.L., Parc Cientìfic de la Universitat de Valencia, Calle del Catedratic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain.
  • Sara Nozal
    DAWAKO Medtech S.L., Parc Cientìfic de la Universitat de Valencia, Calle del Catedratic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain.
  • Jesús Cano
    DAWAKO Medtech S.L., Parc Cientìfic de la Universitat de Valencia, Calle del Catedratic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain.
  • David Primo
    Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School, Department of Endocrinology and Nutrition Hospital Clinico Universitario, University of Valladolid, Valladolid Spain.
  • Eduardo Jorge Godoy
    DAWAKO Medtech S.L., Parc Cientìfic de la Universitat de Valencia, Calle del Catedratic Agustín Escardino Benlloch, 9, 46980 Paterna, Spain.
  • Daniel de Luis
    Center of Investigation of Endocrinology and Clinical Nutrition, Medicine School, Department of Endocrinology and Nutrition Hospital Clinico Universitario, University of Valladolid, Valladolid Spain. Electronic address: dadluis@yahoo.es.